BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17331862)

  • 1. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and metabolic syndrome: an inflammatory condition.
    Scarpellini E; Tack J
    Dig Dis; 2012; 30(2):148-53. PubMed ID: 22722429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte chemotactic protein-1 and its role in insulin resistance.
    Sell H; Eckel J
    Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
    Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
    Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers.
    Lee S; Bacha F; Gungor N; Arslanian S
    J Pediatr; 2008 Feb; 152(2):177-84. PubMed ID: 18206686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome as a concept of adipose tissue disease.
    Oda E
    Hypertens Res; 2008 Jul; 31(7):1283-91. PubMed ID: 18957797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
    Murdolo G; Smith U
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory process of adipose tissue.
    Blüher M
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):24-31. PubMed ID: 18806722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceramides in insulin resistance and lipotoxicity.
    Summers SA
    Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.